Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage

Biochemical and Biophysical Research Communications

Volumn 417, Issue 2, 2012, Pages 710-716

  Lestari, Widya ^a   Ichwan, Solachuddin J A ^b   Otsu, Megumi ^a   Yamada, Shumpei ^a   Iseki, Sachiko ^a   Shimizu, Shihoko ^a   Ikeda, Masa Aki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

ARID3A; Bright; DRIL1; Gene expression; P21WAF1; P53

Indexed keywords

AT RICH INTERACTION DOMAIN 3A PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA BINDING PROTEIN; PROTEIN NOXA; PROTEIN P53; PUMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL CYCLE ARREST; CONTROLLED STUDY; DNA DAMAGE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY;

CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA-BINDING PROTEINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN STABILITY; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855836718     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.003     Document Type: Article

References (21)

1. Wilsker D., Patsialou A., Dallas P.B., Moran E. ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ. 2002, 13:95-106.
2. Wilsker D., Probst L., Wain H.M., Maltais L., Tucker P.W., Moran E. Nomenclature of the ARID family of DNA-binding proteins. Genomics 2005, 86:242-251.
3. Herrscher R.F., Kaplan M.H., Lelsz D.L., Das C., Scheuermann R., Tucker P.W. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 1995, 9:3067-3082.
4. Nixon J.C., Rajaiya J.B., Ayers N., Evetts S., Webb C.F. The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations. Cell. Immunol. 2004, 228:42-53.
5. Suzuki M., Okuyama S., Okamoto S., et al. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer. Oncogene 1998, 17:853-865.
6. Peeper D.S., Shvarts A., Brummelkamp T., Douma S., Koh E.Y., Daley G.Q., Bernards R. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat. Cell Biol. 2002, 4:148-153.
7. Callery E.M., Smith J.C., Thomsen G.H. The ARID domain protein dril1 is necessary for TGF(beta) signaling in Xenopus embryos. Dev. Biol. 2005, 278:542-559.
8. An G., Miner C.A., Nixon J.C., Kincade P.W., Bryant J., Tucker P.W., Webb C.F. Loss of Bright/ARID3a function promotes developmental plasticity. Stem Cells 2010, 28:1560-1567.
9. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
10. Laptenko O., Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 2006, 13:951-961.
11. Ma K., Araki K., Ichwan S.J., Suganuma T., Tamamori-Adachi M., Ikeda M.A. E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53. Mol. Cancer Res. 2003, 1:438-444.
12. Wang L., Wu Q., Qiu P., et al. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem. 2001, 276:43604-43610.
13. Wang B., Xiao Z., Ren E.C. Redefining the p53 response element. Proc. Natl. Acad. Sci. USA 2009, 106:14373-14378.
14. Boyer L.A., Lee T.I., Cole M.F., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
15. Ikeda M.A., Jakoi L., Nevins J.R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 1996, 93:3215-3220.
16. Sumrejkanchanakij P., Tamamori-Adachi M., Matsunaga Y., Eto K., Ikeda M.A. Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Oncogene 2003, 22:8723-8730.
17. Ichwan S.J., Yamada S., Sumrejkanchanakij P., Ibrahim-Auerkari E., Eto K., Ikeda M.A. Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells. Oncogene 2006, 25:1216-1224.
18. Kaplan M.H., Zong R.T., Herrscher R.F., Scheuermann R.H., Tucker P.W. Transcriptional activation by a matrix associating region-binding protein. Contextual requirements for the function of bright. J. Biol. Chem. 2001, 276:21325-21330.
19. Borden K.L., Culjkovic B. Perspectives in PML: a unifying framework for PML function. Front. Biosci. 2009, 14:497-509.
20. Dellaire G., Bazett-Jones D.P. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 2004, 26:963-977.
21. Zong R.T., Das C., Tucker P.W. Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies. EMBO J. 2000, 19:4123-4133.